Opinion

Video

Considerations for Third-Line Treatment in Chronic GVHD

Author(s):

Shernan Holtan, MD,Haris Ali, MD, City of Hope

Medical experts discuss considerations for third-line treatment in chronic GVHD.

Video content above is prompted by the following:

  • Dr Ali: For patients showing inadequate response to second-line therapies, what factors guide your treatment selection in third line and beyond?

Please discuss the role of safety concerns, organ involvement, severity, etc, in your decision to use one agent over another.

Related Videos
2 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content